Oliver Hampton, PhD

Chief Data Officer

Oliver Hampton, PhD, joined Southern Research in 2023 and brings more than 15 years of industry and academic experience innovating novel sequencing techniques and computational analysis workflows for a wide range of multi-omic and clinical data applications for RWD/RWE, precision medicine, therapeutic target discovery, and clinical trial matching.

Prior to joining Southern Research, Hampton served as Vice President of Bioinformatics and Biostatistics at Aster Insights, a health informatics solutions firm dedicated to improving cancer care via the use of precision medicine. He was also Group Leader of Memorial Sloan Kettering Cancer Center’s Platform Informatics core facility, where he led a team responsible for the design, implementation, and maintenance of sophisticated and automated analysis workflows that transform next generation sequencing data into high-confidence data ready for clinical actionability and research hypothesis generation. Hampton was also Research Assistant Professor in the Human Genome Sequencing Center at Baylor College of Medicine where his research focused on the genetics of pediatric malignancies.

Hampton graduated from New Mexico State University with a Bachelor’s degree in biochemistry and a Master’s degree in computer science. At Baylor College of Medicine, he earned his Ph.D. in Structural and Computational Biology and Molecular Biophysics.

Related Articles

Birmingham receives federal Tech Hub designation and opportunity to apply for millions in federal funding

October 23, 2023

Birmingham’s metro area is among 31 regions across the country named today as a federal Tech Hub, competing successfully under a new program that could ultimately inject $75 million into the local economy. The designation followed a highly competitive process with nearly 200 applications natio...
Read More

Southern Research launches Venture Studio

November 22, 2022

Southern Research has launched a Venture Studio to develop startups that will bring new therapeutic products to market. In conjunction with its partners, Southern Research has more than 20 drug programs currently in preclinical development. These programs hold enormous potential for patients in t...
Read More

Southern Research and Rhodium Scientific send bacteria to space to explore potential cancer treatments

November 7, 2022

Southern Research and Rhodium Scientific have partnered to send bacteria to space on a mission to find new hope for people with cancer. When Northrop Grumman’s Antares rocket launched ...
Read More